[go: up one dir, main page]

WO2011061761A3 - Pharmaceutical composition for parenteral use comprising mycophenolate mofetil - Google Patents

Pharmaceutical composition for parenteral use comprising mycophenolate mofetil Download PDF

Info

Publication number
WO2011061761A3
WO2011061761A3 PCT/IN2010/000745 IN2010000745W WO2011061761A3 WO 2011061761 A3 WO2011061761 A3 WO 2011061761A3 IN 2010000745 W IN2010000745 W IN 2010000745W WO 2011061761 A3 WO2011061761 A3 WO 2011061761A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycophenolate mofetil
pharmaceutical composition
parenteral use
pharmaceutical compositions
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000745
Other languages
French (fr)
Other versions
WO2011061761A2 (en
Inventor
Vj. Pakalapati Ramani
Nagaraj Amminabavi
Subhash Gore
Manoj Pananchukunnath
Rajesh Gupta
Indu Bhushan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Matrix Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd filed Critical Matrix Laboratories Ltd
Publication of WO2011061761A2 publication Critical patent/WO2011061761A2/en
Anticipated expiration legal-status Critical
Publication of WO2011061761A3 publication Critical patent/WO2011061761A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to pharmaceutical compositions comprising an immunosuppressant, for parenteral administration. More particularly, the invention relates to pharmaceutical compositions for parenteral administration, which comprises mycophenolate mofetil or its pharmaceutically acceptable salt thereof.
PCT/IN2010/000745 2009-11-17 2010-11-16 Pharmaceutical composition for parenteral use Ceased WO2011061761A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2821CH2009 2009-11-17
IN2821/CHE/2009 2009-11-17

Publications (2)

Publication Number Publication Date
WO2011061761A2 WO2011061761A2 (en) 2011-05-26
WO2011061761A3 true WO2011061761A3 (en) 2013-04-25

Family

ID=44060142

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000745 Ceased WO2011061761A2 (en) 2009-11-17 2010-11-16 Pharmaceutical composition for parenteral use

Country Status (1)

Country Link
WO (1) WO2011061761A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106943359B (en) * 2016-01-06 2020-05-01 山东新时代药业有限公司 Stable mycophenolate mofetil for injection and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087174A1 (en) * 2003-04-01 2004-10-14 Novartis Ag Parenteral formulation of mycophenolic acid, a salt or prodrug thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087174A1 (en) * 2003-04-01 2004-10-14 Novartis Ag Parenteral formulation of mycophenolic acid, a salt or prodrug thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RXLIST THE INTERNET DRUG INDEX: "CellCept", 29 June 2012 (2012-06-29), XP002692430, Retrieved from the Internet <URL:http://www.rxlist.com/script/main/rxlist.asp?articlekey=66621&pf=3&page=1> [retrieved on 20130219] *

Also Published As

Publication number Publication date
WO2011061761A2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2010036407A3 (en) Antiviral nucleoside analogs
WO2007086001A3 (en) Novel pyridine derivatives
WO2009111653A3 (en) Antiviral therapeutic agents
MY154909A (en) Novel thiophene derivatives
MX2010005889A (en) Novel thiophene derivatives.
WO2010092090A3 (en) Novel salts of sitagliptin
WO2012021715A3 (en) Stable formulations of linaclotide
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2008057550A3 (en) Stabilization of vaccines by lyophilization
WO2007150025A3 (en) Purinone derivatives as hm74a agonists
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2011157722A3 (en) Solid ivabradine-containing composition
EA201300990A1 (en) PARENTAL INTRODUCTION OF TAPENTADOL
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2012106665A3 (en) Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
WO2010049449A3 (en) Novel salts of sunitinib
WO2011122872A3 (en) Composition comprising coumestrol or a bean extract containing coumestrol
WO2009071650A3 (en) Amide compounds as boosters of antivirals
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2011135580A3 (en) Pharmaceutical compositions of sirolimus
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10831265

Country of ref document: EP

Kind code of ref document: A2